AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SELLAS Life Sciences Group, Inc. Director's Dealing 2011

Apr 21, 2011

Director's Dealing

Opens in your device viewer

Issuer: RXI PHARMACEUTICALS CORP (RXII)
CIK: 0001390478
Period of Report: 2011-04-13

Reporting Person: SCHWARTZ MARK W. (EVP Chief Operating Officer)